Trial Profile
Effects of Gadobutrol on background parenchymal enhancement in breast dynamic MRI
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2022
Price :
$35
*
At a glance
- Drugs Gadobutrol (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- 12 Sep 2022 Status changed from active, no longer recruiting to completed.
- 22 Sep 2018 Planned End Date changed from 31 Jan 2018 to 31 Jul 2018.
- 08 Mar 2017 New trial record